1. Home
  2. MXCT vs LNKB Comparison

MXCT vs LNKB Comparison

Compare MXCT & LNKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • LNKB
  • Stock Information
  • Founded
  • MXCT 1999
  • LNKB 2018
  • Country
  • MXCT United States
  • LNKB United States
  • Employees
  • MXCT N/A
  • LNKB N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LNKB
  • Sector
  • MXCT Health Care
  • LNKB
  • Exchange
  • MXCT Nasdaq
  • LNKB Nasdaq
  • Market Cap
  • MXCT 242.4M
  • LNKB 277.1M
  • IPO Year
  • MXCT 2021
  • LNKB N/A
  • Fundamental
  • Price
  • MXCT $1.40
  • LNKB $7.34
  • Analyst Decision
  • MXCT Buy
  • LNKB Strong Buy
  • Analyst Count
  • MXCT 4
  • LNKB 1
  • Target Price
  • MXCT $7.50
  • LNKB $9.00
  • AVG Volume (30 Days)
  • MXCT 1.2M
  • LNKB 44.2K
  • Earning Date
  • MXCT 08-06-2025
  • LNKB 10-27-2025
  • Dividend Yield
  • MXCT N/A
  • LNKB 4.05%
  • EPS Growth
  • MXCT N/A
  • LNKB N/A
  • EPS
  • MXCT N/A
  • LNKB 1.01
  • Revenue
  • MXCT $35,754,000.00
  • LNKB $121,982,000.00
  • Revenue This Year
  • MXCT N/A
  • LNKB $18.26
  • Revenue Next Year
  • MXCT $14.79
  • LNKB N/A
  • P/E Ratio
  • MXCT N/A
  • LNKB $7.35
  • Revenue Growth
  • MXCT N/A
  • LNKB 79.01
  • 52 Week Low
  • MXCT $1.26
  • LNKB $6.00
  • 52 Week High
  • MXCT $5.20
  • LNKB $7.98
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 31.00
  • LNKB 54.95
  • Support Level
  • MXCT $1.37
  • LNKB $7.20
  • Resistance Level
  • MXCT $1.48
  • LNKB $7.51
  • Average True Range (ATR)
  • MXCT 0.09
  • LNKB 0.21
  • MACD
  • MXCT 0.02
  • LNKB 0.03
  • Stochastic Oscillator
  • MXCT 46.43
  • LNKB 72.46

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About LNKB LINKBANCORP Inc.

Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.

Share on Social Networks: